Clinical Trial

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Name: A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults — clinical trial record (NCT07628049)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investigational hMPV vaccine in younger and older adults.

Trial Details

NCT Number	NCT07628049
Lead Sponsor	GlaxoSmithKline
Conditions	Respiratory Syncytial Virus Infections+Metapneumovirus
Enrollment	1,808 participants
Start Date	2026-06-03
Primary Completion	2029-04-05 (estimated)
Study Completion	2029-04-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-04